Rosacea
Oracea demonstrated up to a 61% reduction in inflammatory lesions in trial
Published in Drug Week, July 8th, 2005
The trials enrolled a total of 537 patients in 28 centers across the U.S. Patients in the study were administered either Oracea or placebo once a day for 16 weeks.
Dr. James del Rosso, clinical assistant professor, department of dermatology, University of Nevada School of Medicine, Las Vegas, Nevada, said: "With millions of patients seeking treatment for rosacea, it is exciting that the studies with Oracea...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-07-08)
More Articles from Drug Week
- Anemia
Exploratory analysis of CERA data shows sustained and stable control of anemia - Cardiovascular Therapy
Valsartan/HCTZ combination is good for patients with added CV risk - Drug Development
Hematide clinical results demonstrate potent effect on red blood cell production - Drug Development
U.S. FDA grants tentative approval of Zolpidem ODT for sleep disorders - Acetaminophen
Fever control in septic shock examined, benefit or harm probed - Acinetobacter Baumannii Outbreaks
3rd-gen. cephalosporin therapy risk for VEB-1 ESBL A. baumannii outbreak - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
